Projects
Elucidating psychological and social risk factors for low back pain in highly physically active adolescents: a case study in female pre-professional dancers. University of Antwerp
In vitro studies into the downstream regulatory mechanism whereby LRP4 and sclerostin together regulate Wnt siganling activity. University of Antwerp
Head impact biomechanics for protecting the active ageing population KU Leuven
In Europe, the incidence of fatal and hospitalized traumatic brain injury (TBI) is 262/100.000/year. Lately, a significant increase in the proportion of elderly patients suffering TBI has been observed. This can be explained by changing demographics, better health status allowing them to remain fully active, but also by the presumed mechanical vulnerability of the ageing brain and surrounding tissues.
While staying active is rightfully ...
The role of innate-like T cells in combined gut-joint disease in spondyloarthritis Ghent University
Spondyloarthritis (SpA) covers a group of common inflammatory and chronic musculoskeletal
diseases that affect up to 1% of the Western population. They are characterized by inflammation
and tissue damage of the joints, leading to irreversible damage and loss of motoric function.
Interestingly, we demonstrated that about 50% of SpA patients were found to have microscopic
signs of gut inflammation, without having ...
How T cell autoreactivity develops in early rheumatoid arthritis: the smoking gun hypothesis Ghent University
Rheumatoid arthritis (RA) is one of the most common autoimmune diseases and is characterized by
uncontrolled inflammation of the synovial tissue, eventually leading to joint destruction. RA is a
complex disease resulting by a combination of genetic and environmental factors. The most
profound genetic association exists within MHC-II genes suggesting that RA pathology is Thelper cell
dependent. One of the strongest ...
Identification and validation of novel autoantibodies in idiopathic in flammatory myopathy. KU Leuven
We aim to discover novel antibodies in IIM-patients and to develop an ELISA screening tool. We will establisch the prevalence and the associated disease characteristics of newly identified antibodies in IIM patients and controls.